Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Lori A. Woods

At a glance: Lori A. Woods is Director at Perspective Therapeutics (CATX). Their latest SEC Form 4, filed Nov 16, 2026, reported a purchase of $20K. On file: 1 purchase line ($20K) and 0 sale lines ($0).

Disclosed holdings: about $21K of CATX stock: 28,557 shares reported on their latest Form 4 (filed Nov 16, 2026), valued at the Nov 20, 2026 close of $0.75. This counts only CATX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Perspective Therapeutics, Inc. (CATX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$2K
Total bought / sold$20K / $0

Lori A. Woods's InsiderPrint

9 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.

InsiderPrint of Lori A. Woods: 9 trades, 2020 to 20262020: 2 buys, 0 sales2021: 0 buys, 0 sales2022: 2 buys, 0 sales2023: 1 buy, 0 sales2024: 2 buys, 0 sales2025: 1 buy, 0 sales2026: 1 buy, 0 sales

Reading this print: Almost only buys, trading about once a year, typically $34K a trade.

  • Bump outward: a purchase (9)
  • Dent inward: a sale (0)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Kevin M. CharltonDirector · EVLV · 99% match
  2. Thane WettigCEO · KYNB · 99% match
  3. William WesemannDirector · ACON · 99% match
  4. Eric R. NewellCFO · EGBN · 99% match
  5. David A. PeacockCEO · ADV · 99% matchTheir buys since 2023: 6 of 12 beat the S&P 500

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Every purchase since 2023

From the SEC's insider data sets: each open-market buy by Lori A. Woods, matched to how the stock did over the next 90 days against the S&P 500.

3 of 3 buys beat the S&P 500 (100%), median +32.4% vs. the index. Small sample: treat with care. All insider buys: 46%.

StockFiled90 days vs. S&P 500
CATXJun 18, 2024+7.0%
CATXJun 13, 2024+32.4%
CATXDec 19, 2023+177.0%

Buys made close together in one stock count once. Price-only returns; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 16SEC CATXPerspective Therapeutics, Inc.Off-schedule buyStake +494%Past buys 3/3 beat S&P Buy 23,75028,557 held (+494%) $0.84 $20K -11.5%
  • Buy

    Director Lori A Woods bought $20K of CATX at $0.84 — first open-market purchase in our records; raises the stake by 494%.

Follow Lori A. Woods

Get one email when Lori A. Woods files a new purchase or sale. Free.

At most one email a day about Lori A. Woods, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.